Tonix Pharmaceuticals

0 followers


Tonix is developing innovative pharmaceutical products to address major public health challenges. In addition to Tonmya for PTSD, Tonix is developing TNX-601 (tianeptine oxalate), a clinical candidate at pre-IND (Investigational New Drug) application stage, designed as a daytime treatment for PTSD,... Read more

Industries

Employees

51-200

Links


Org chart

Seth Lederman
Co-Founder, CEO & Chairman
Collapse
Gregory Sullivan
Chief Medical Officer
Siobhan Fogarty
EVP, Product Development
Sina Bavari
EVP, Infectious Disease Research & Development
Jean Engels
Senior Director Of Biostatistics
Ram Patalapati
Head, R&d Quality

Board & advisors